5-161692119-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_000811.3(GABRA6):āc.1005C>Gā(p.Ala335=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.536 in 1,613,736 control chromosomes in the GnomAD database, including 236,907 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.48 ( 18132 hom., cov: 33)
Exomes š: 0.54 ( 218775 hom. )
Consequence
GABRA6
NM_000811.3 synonymous
NM_000811.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.318
Genes affected
GABRA6 (HGNC:4080): (gamma-aminobutyric acid type A receptor subunit alpha6) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 5-161692119-C-G is Benign according to our data. Variant chr5-161692119-C-G is described in ClinVar as [Benign]. Clinvar id is 1169911.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.318 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.562 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA6 | NM_000811.3 | c.1005C>G | p.Ala335= | synonymous_variant | 8/9 | ENST00000274545.10 | NP_000802.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA6 | ENST00000274545.10 | c.1005C>G | p.Ala335= | synonymous_variant | 8/9 | 1 | NM_000811.3 | ENSP00000274545 | P1 | |
GABRA6 | ENST00000523217.5 | c.975C>G | p.Ala325= | synonymous_variant | 8/9 | 5 | ENSP00000430527 | |||
GABRA6 | ENST00000521520.1 | n.998C>G | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.479 AC: 72734AN: 151912Hom.: 18131 Cov.: 33
GnomAD3 genomes
AF:
AC:
72734
AN:
151912
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.481 AC: 121057AN: 251464Hom.: 30595 AF XY: 0.488 AC XY: 66374AN XY: 135904
GnomAD3 exomes
AF:
AC:
121057
AN:
251464
Hom.:
AF XY:
AC XY:
66374
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.542 AC: 792173AN: 1461706Hom.: 218775 Cov.: 50 AF XY: 0.540 AC XY: 392925AN XY: 727170
GnomAD4 exome
AF:
AC:
792173
AN:
1461706
Hom.:
Cov.:
50
AF XY:
AC XY:
392925
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.478 AC: 72744AN: 152030Hom.: 18132 Cov.: 33 AF XY: 0.476 AC XY: 35390AN XY: 74288
GnomAD4 genome
AF:
AC:
72744
AN:
152030
Hom.:
Cov.:
33
AF XY:
AC XY:
35390
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1191
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Childhood absence epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | - - |
GABRA6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at